Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dan G Duda

Showing results (41-50 of 261) with videos related to

Pageof 27
Sort By:
The Lancet. Oncology|July 17, 2015
Chemotherapy and antiangiogenics in biliary tract cancerLipika Goyal, Dawn Q Chong, Dan G Duda, et al.
American Journal of Cancer Research|August 9, 2011
Direct evidence for lineage-dependent effects of bone marrow stromal cells on tumor progressionMichelle R Dawson, Sung-Suk Chae, Rakesh K Jain, et al.
Nature Protocols|April 21, 2007
A protocol for phenotypic detection and enumeration of circulating endothelial cells and circulating progenitor cells in human bloodDan G Duda, Kenneth S Cohen, David T Scadden, et al.
Nature Reviews. Clinical Oncology|March 10, 2011
HCC and angiogenesis: possible targets and future directionsAndrew X Zhu, Dan G Duda, Dushyant V Sahani, et al.
Journal of the National Cancer Institute|May 11, 2012
Neovascularization after irradiation: what is the source of newly formed vessels in recurring tumors?Sergey V Kozin, Dan G Duda, Lance L Munn, et al.
Nature Clinical Practice. Oncology|January 13, 2006
Lessons from phase III clinical trials on anti-VEGF therapy for cancerRakesh K Jain, Dan G Duda, Jeffrey W Clark, et al.
Cancer Journal (Sudbury, Mass.)|August 13, 2009
Development of sunitinib in hepatocellular carcinoma: rationale, early clinical experience, and correlative studiesAndrew X Zhu, Dan G Duda, Dushyant V Sahani, et al.
Trends in Molecular Medicine|April 28, 2007
VEGF-targeted cancer therapy strategies: current progress, hurdles and future prospectsDan G Duda, Tracy T Batchelor, Christopher G Willett, et al.
Nature Reviews. Clinical Oncology|March 7, 2018
Enhancing cancer immunotherapy using antiangiogenics: opportunities and challengesDai Fukumura, Jonas Kloepper, Zohreh Amoozgar, et al.
Nature Reviews. Cancer|June 25, 2011
Is vasculogenesis crucial for the regrowth of irradiated tumours?Sergey V Kozin, Dan G Duda, Lance L Munn, et al.
Pageof 27

Showing results (41-50 of 261) with videos related to

Sort By:
Pageof 27
The Lancet. Oncology|July 17, 2015
Chemotherapy and antiangiogenics in biliary tract cancerLipika Goyal, Dawn Q Chong, Dan G Duda, et al.
American Journal of Cancer Research|August 9, 2011
Direct evidence for lineage-dependent effects of bone marrow stromal cells on tumor progressionMichelle R Dawson, Sung-Suk Chae, Rakesh K Jain, et al.
Nature Protocols|April 21, 2007
A protocol for phenotypic detection and enumeration of circulating endothelial cells and circulating progenitor cells in human bloodDan G Duda, Kenneth S Cohen, David T Scadden, et al.
Nature Reviews. Clinical Oncology|March 10, 2011
HCC and angiogenesis: possible targets and future directionsAndrew X Zhu, Dan G Duda, Dushyant V Sahani, et al.
Journal of the National Cancer Institute|May 11, 2012
Neovascularization after irradiation: what is the source of newly formed vessels in recurring tumors?Sergey V Kozin, Dan G Duda, Lance L Munn, et al.
Nature Clinical Practice. Oncology|January 13, 2006
Lessons from phase III clinical trials on anti-VEGF therapy for cancerRakesh K Jain, Dan G Duda, Jeffrey W Clark, et al.
Cancer Journal (Sudbury, Mass.)|August 13, 2009
Development of sunitinib in hepatocellular carcinoma: rationale, early clinical experience, and correlative studiesAndrew X Zhu, Dan G Duda, Dushyant V Sahani, et al.
Trends in Molecular Medicine|April 28, 2007
VEGF-targeted cancer therapy strategies: current progress, hurdles and future prospectsDan G Duda, Tracy T Batchelor, Christopher G Willett, et al.
Nature Reviews. Clinical Oncology|March 7, 2018
Enhancing cancer immunotherapy using antiangiogenics: opportunities and challengesDai Fukumura, Jonas Kloepper, Zohreh Amoozgar, et al.
Nature Reviews. Cancer|June 25, 2011
Is vasculogenesis crucial for the regrowth of irradiated tumours?Sergey V Kozin, Dan G Duda, Lance L Munn, et al.
Pageof 27